Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12TAKEDA PHARMS USA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BRIGATINIB

US Patent Number : 9611283

Drug Substance Claim :

Drug Product Claim :

Application Number : 208772

Patent Use Code : U-2837

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-04-10

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BRIGATINIB

US Patent Number : 9611283

Drug Substance Claim :

Drug Product Claim :

Application Number : 208772

Patent Use Code : U-2837

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-04-10

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BRIGATINIB

US Patent Number : 9611283

Drug Substance Claim :

Drug Product Claim :

Application Number : 208772

Patent Use Code : U-2837

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-04-10

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BRIGATINIB

US Patent Number : 9273077

Drug Substance Claim :

Drug Product Claim :

Application Number : 208772

Patent Use Code : U-2837

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-05-21

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BRIGATINIB

US Patent Number : 9273077

Drug Substance Claim :

Drug Product Claim :

Application Number : 208772

Patent Use Code : U-2837

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-05-21

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BRIGATINIB

US Patent Number : 9273077

Drug Substance Claim :

Drug Product Claim :

Application Number : 208772

Patent Use Code : U-2837

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-05-21

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BRIGATINIB

US Patent Number : 10385078

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208772

Patent Use Code : U-2837

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-10

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BRIGATINIB

US Patent Number : 10385078

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208772

Patent Use Code : U-2837

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-10

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BRIGATINIB

US Patent Number : 10385078

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208772

Patent Use Code : U-2837

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-11-10

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BRIGATINIB

US Patent Number : 9012462

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 208772

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-04-28

blank